0597-0390Level 3
Trijardy XR (empagliflozin, linagliptin, metformin hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
**Strength:** 25; 5; 1000 mg/1; mg/1; mg/1
**Dosage form:** Tablet, Extended Release
**Route:** Oral
**Labeler:** Boehringer Ingelheim Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA212614)
**Pharmacologic class:** Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0597-0390Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.